These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10586096)

  • 1. Persistent T cell anergy in human type 1 diabetes.
    Dosch H; Cheung RK; Karges W; Pietropaolo M; Becker DJ
    J Immunol; 1999 Dec; 163(12):6933-40. PubMed ID: 10586096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell activation and anergy to islet cell antigen in type I diabetes.
    Miyazaki I; Cheung RK; Gaedigk R; Hui MF; Van der Meulen J; Rajotte RV; Dosch HM
    J Immunol; 1995 Feb; 154(3):1461-9. PubMed ID: 7822811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
    Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
    J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy.
    Taams LS; van Eden W; Wauben MH
    J Immunol; 1999 Feb; 162(4):1974-81. PubMed ID: 9973467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides.
    Abulafia-Lapid R; Elias D; Raz I; Keren-Zur Y; Atlan H; Cohen IR
    J Autoimmun; 1999 Mar; 12(2):121-9. PubMed ID: 10047432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
    Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H
    J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies and associated T-cell responses to determinants within the 831-860 region of the autoantigen IA-2 in Type 1 diabetes.
    Weenink SM; Lo J; Stephenson CR; McKinney PA; Ananieva-Jordanova R; Rees Smith B; Furmaniak J; Tremble JM; Bodansky HJ; Christie MR
    J Autoimmun; 2009 Sep; 33(2):147-54. PubMed ID: 19447008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes.
    Narendran P; Williams AJ; Elsegood K; Leech NJ; Dayan CM
    Diabetes Metab Res Rev; 2003; 19(1):52-9. PubMed ID: 12592644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient.
    Schloot NC; Batstra MC; Duinkerken G; De Vries RR; Dyrberg T; Chaudhuri A; Behan PO; Roep BO
    J Autoimmun; 1999 Jun; 12(4):289-96. PubMed ID: 10330300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies.
    Marttila J; Huttunen S; Vaarala O; Suzuki K; Elliott JF; Närvänen A; Knip M; Simell O; Ilonen J
    J Autoimmun; 2008 Sep; 31(2):142-8. PubMed ID: 18565729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study.
    Seyfert-Margolis V; Gisler TD; Asare AL; Wang RS; Dosch HM; Brooks-Worrell B; Eisenbarth GS; Palmer JP; Greenbaum CJ; Gitelman SE; Nepom GT; Bluestone JA; Herold KC
    Diabetes; 2006 Sep; 55(9):2588-94. PubMed ID: 16936208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
    Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B
    Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes.
    Faresjö MK; Vaarala O; Thuswaldner S; Ilonen J; Hinkkanen A; Ludvigsson J
    Diabetes Metab Res Rev; 2006; 22(6):462-70. PubMed ID: 16572494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deviation of islet autoreactivity to cryptic epitopes protects NOD mice from diabetes.
    Song A; Winer S; Tsui H; Sampson A; Pasceri P; Ellis J; Elliott JF; Dosch HM
    Eur J Immunol; 2003 Feb; 33(2):546-55. PubMed ID: 12645954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects.
    Semana G; Gausling R; Jackson RA; Hafler DA
    J Autoimmun; 1999 Jun; 12(4):259-67. PubMed ID: 10330297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes.
    Endl J; Rosinger S; Schwarz B; Friedrich SO; Rothe G; Karges W; Schlosser M; Eiermann T; Schendel DJ; Boehm BO
    Diabetes; 2006 Jan; 55(1):50-60. PubMed ID: 16380476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity.
    Durinovic-Belló I; Boehm BO; Ziegler AG
    J Autoimmun; 2002 Feb; 18(1):55-66. PubMed ID: 11869047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
    Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
    Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2, but not interleukin-15, is required to terminate experimentally induced clonal T-cell anergy.
    Bendiksen S; Rekvig OP
    Scand J Immunol; 2004; 60(1-2):64-73. PubMed ID: 15238074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.